Log In
Print
BCIQ
Print
Print this Print this
 

OTX008

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionGalectin-1 inhibitor
Molecular Target Galectin-1 (LGALS1)
Mechanism of ActionGalectin antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today